advertisement

Topcon

Abstract #5724 Published in IGR 2-1

Intravitreal triamcinolone and elevated intraocular pressure

Wingate RJ; Beaumont PE
Australian and New Zealand Journal of Ophthalmology 1999; 27:431-432


PURPOSE: To ascertain whether intravitreal triamcinolone given for subretinal neovascularization is associated with an ocular pressure rise. METHODS: A total of 113 patients with angiographically proven subretinal neovascularization were enrolled into a prospective study of the effects of intravitrea triamcinolone. Intraocular pressure was one of the parameters studied. RESULTS: Approximately 30% of the study group developed a significant rise (> or = 5 mmHg) in intraocular pressure above baseline during the first three months. CONCLUSIONS: Patients considering this form of treatment should be fully informed of the known risks of intraocular injections of steroids.

Dr. R.J. Wingate, <#> rwingate@internet-australia.com


Classification:

9.4.1 Steroid-induced glaucoma (Part of: 9 Clinical forms of glaucomas > 9.4 Glaucomas associated with other ocular and systemic disorders)



Issue 2-1

Change Issue


advertisement

Oculus